Cancer News and Research

Latest Cancer News and Research

Schering-Plough and Bayer form strategic alliance

Schering-Plough Corporation has announced that it has entered into a strategic agreement with Bayer designed to maximize the companies' pharmaceutical resources while maintaining each company's own strategic interests.

13 Sep 2004

Researchers have discovered a possible way to distinguish lethal from localized prostate cancers

If future studies show their test -- measuring the level of activity of a signaling pathway called Hedgehog -- can predict which prostate cancers will spread, the results could revolutionize decision making processes for prostate cancer patients, the researchers say.

13 Sep 2004

Health problems among timber workers exposed to industry chemical PCP are to be investigated

The project, funded by the Ministry of Health, aims to ascertain whether timber workers exposed to the PCPs (pentachlorophenols) are dying earlier, getting cancers more often and suffering more chronic health problems, including fatigue, nausea and neuropsychological dysfunction.

13 Sep 2004

CA125 blood test may be superior to standard imaging techniques like CT scans

A new study shows that the CA125 blood test, which measures the level of protein produced by ovarian cancer cells in the blood, may be superior to standard imaging techniques like CT scans in predicting survival in patients with recurrent ovarian cancer.

13 Sep 2004

Women starting mammography on time, but failing to follow up

A new study finds most women now follow the recommendation to receive their first screening mammogram at age 40, but there is widespread failure to return promptly for subsequent exams and several sub-populations of women still are not being screened by the recommended age.

12 Sep 2004

Cancer survivors' other medical problems poorly managed

People who survive cancer are less likely to receive necessary care for a wide range of other non-cancer-related medical problems according to a new study published September 13, 2004 in the online edition of CANCER, a peer- reviewed journal of the American Cancer Society.

12 Sep 2004

New study will examine why people live exceptionally long lives

Researchers at Washington University School of Medicine in St. Louis will head an ambitious study of people who live exceptionally long and healthy lives to identify the factors that account for their longevity.

10 Sep 2004

PSA test is now all but useless for predicting prostate cancer risk

The PSA test, commonly used as a screening tool for detecting prostate cancer, is now all but useless for predicting prostate cancer risk, according to Stanford University School of Medicine researchers.

10 Sep 2004

Unique technology with the potential to test for hundreds of diseases, cancers and genes in one, cheap, test

Queensland, Australia PhD student Angus Johnston has invented a unique technology with the potential to test for hundreds of diseases, cancers and genes in one, cheap, test. He hopes that within five years the technology will be available in a desktop unit for less than AU$30,000.

10 Sep 2004

Cancer drug may reduce kidney disease in lupus

A drug that is already being tested as an anticancer agent, especially in lymphoma, may also reduce the kidney disease that is a result of systemic lupus, according to a researcher at Wake Forest University Baptist Medical Center.

10 Sep 2004

New view of chromatin and gene activity

A genome - the DNA instructions for an organism - does not act alone. DNA is packaged with proteins into 'chromatin', which may be more or less tightly condensed. A popular proposal is that active genes are in 'open' chromatin (to allow access to them) and inactive genes are in tightly packed 'compact' chromatin.

10 Sep 2004

Disruption of protein folding causes neurodegeneration, mental retardation

Excess accumulation in brain cells of a fat molecule called GM1-ganglioside (GM1) disrupts the folding of newly assembled proteins into their proper shapes, triggering nerve degeneration and mental retardation in children.

10 Sep 2004

Efforts to prevent school children smoking are not targeted early enough, as children experimenting with tobacco by age seven

New Zealand based research on youth tobacco use suggests that current efforts to prevent school children smoking are not targeted early enough, as it found a significant number are already experimenting with tobacco by age seven.

10 Sep 2004

Painful and damaging chemotherapy may one day be a thing of the past

Researchers at the Georgia Institute of Technology and Purdue University have developed nano-sized particles that can target and trick cancer cells into absorbing them.

10 Sep 2004

MRI most effective for detecting breast cancer for women with breast cancer gene mutations

MRI is more accurate for detecting breast cancer than mammography, ultrasound or clinical breast examination alone, in women who carry the BRCA1 or BRCA2 gene mutation, according to a study in the September 15 issue of JAMA.

10 Sep 2004

Gene mutations cause 85 percent of colon cancers

Mutations in the adenomatous polyposis coli (APC) tumor suppressor gene have been found to cause 85 percent of colon cancers.

9 Sep 2004

New treatment for T-cell acute lymphoblastic leukaemia

IL-7, a hormone-like protein involved in cell-cell interaction, has been associated with increased survival and expansion of T-cell acute lymphoblastic leukaemia (T-ALL).

9 Sep 2004

Protein sources, such as beef and beans beneficial in lowering childhood leukemia risk

A new study suggests that eating more vegetables, fruit and protein before pregnancy may lower the risk of having a child who develops leukemia, the most common childhood cancer in the United States.

8 Sep 2004

Growing up in polluted towns and cities increases risk of lung health issues

Children who grow up in towns and cities with high pollution levels are at increased risk of lung health issues or low functioning lungs. New research suggests that pollutants from vehicle emissions and fossil fuels have an adverse effect on a child's lung development and can also lower childrens lifetime breathing capacity.

8 Sep 2004

Studies of human genetic variation have found strong evidence for the action of natural selection

One of the most comprehensive studies of the forces that have shaped patterns of human genetic variation has found strong evidence for the action of natural selection, which may help explain why certain people are at risk for a variety of conditions and others are not.

8 Sep 2004

Cancer News and Research

Latest Cancer News and Research

Schering-Plough and Bayer form strategic alliance

Researchers have discovered a possible way to distinguish lethal from localized prostate cancers

Health problems among timber workers exposed to industry chemical PCP are to be investigated

CA125 blood test may be superior to standard imaging techniques like CT scans

Women starting mammography on time, but failing to follow up

Cancer survivors' other medical problems poorly managed

New study will examine why people live exceptionally long lives

PSA test is now all but useless for predicting prostate cancer risk

Unique technology with the potential to test for hundreds of diseases, cancers and genes in one, cheap, test

Cancer drug may reduce kidney disease in lupus

New view of chromatin and gene activity

Disruption of protein folding causes neurodegeneration, mental retardation

Efforts to prevent school children smoking are not targeted early enough, as children experimenting with tobacco by age seven

Painful and damaging chemotherapy may one day be a thing of the past

MRI most effective for detecting breast cancer for women with breast cancer gene mutations

Gene mutations cause 85 percent of colon cancers

New treatment for T-cell acute lymphoblastic leukaemia

Protein sources, such as beef and beans beneficial in lowering childhood leukemia risk

Growing up in polluted towns and cities increases risk of lung health issues

Studies of human genetic variation have found strong evidence for the action of natural selection

Understanding the DNA Damage Response in Innate Immunity eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in